Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “ 8) Article 17 shall be worded as follows: Article 17. 532) with the following paragraph 156: «.

Seed-To-Sale

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. The charity was eventually instructed to pull an advertisement for the study by the ethics committee that conditionally approved the trial.

Medicine

Cannabis Law Report

JUNE 11, 2019

Despite the recent legalization of cannabis, a framework for access to cannabis for medical purposes still exists, but under new regulations passed under the authority of the Cannabis Act. Heran , 2011 BCSC 727. Silk , 2011 BCCA 135. Prior to that, cannabis was regulated under the Controlled Drugs and Substances Act.

Chronic Pain

CannaMD

NOVEMBER 6, 2019

As more people gain access to medical marijuana, dependence on opioids for pain relief is likely to decline. billion opioid prescriptions written between 2011 and 2018. The authors state: We find that recreational and medical cannabis access laws reduce the number of morphine milligram equivalents prescribed each year by 6.9

Marijuana

The Cannigma

FEBRUARY 1, 2023

Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. To date, very few human clinical trials have been conducted to assess the effectiveness of THC or CBD in treating cancer. Use harm reduction techniques (i.e.

Clinical Trials

Otherside Farms

JANUARY 25, 2019

Norman Smith: “Since I am the only successful patient in the clinical trial, to take away something that’s been part of a successful regimen does not make any sense” In September 2010, Smith became eligible for a liver transplant, but after testing positive for marijuana in February he was removed from the transplant list.

Patients

SMPL

MAY 26, 2020

At the time of Samantha Miller’s summit in 2011, THC was the sole chemical “face” of the plant. In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At

CBD

The Cannigma

FEBRUARY 11, 2021

The Cannabis Enigma Podcast is a co-production of Americans for Safe Access and The Cannigma. You know, started doing clinical trials through Zelda Therapeutics, and all the other things I’ve done. Produced by Michael Schaeffer Omer-Man and Elana Goldberg, and edited and mixed by Michael Schaeffer Omer-Man. Music by Desca.

Wellness and Beauty

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. 640, 640 (2011). See Rachel Quibell et al., Ketamine , 41 J. Mitchell et al.,

Research and Development

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/ingmargorman/ [link]. in/spencer-hawkswell-210a8189/ [link]. in/psilocybin/ [link].

Research and Development